Biomarkers for Neurodegenerative Disorders

 

Sanna-Kaisa Herukka
Research Fellow

University of Eastern Finland
Institute of Clinical Medicine / Neurology
P.O.Box 1627 (Yliopistonranta 1C)
FI-70211 Kuopio
Finland

+358-(0)40-548 6247
Fax +358-(0)17-162 048
sanna-kaisa.herukka (at) uef.fi

 

ACADEMIC DEGREES

  • BM, 2005
  • MSc (Applied biotechnology), 2008
  • PhD (Neurosciences), 2009

PROFESSIONAL EXPERIENCE

  • Graduate Student, Dept of Neuroscience and Neurology, University of Kuopio 2002- 2007
  • Researcher, Dept of Neurology, University of Kuopio, 2007 –

MAJOR RESEARCH INTERESTS 

  • Biological markers for neurodegenerative disease, particularly Alzheimer's disease
  • Mild cognitive impairment and early Alzheimer's disease

Publications in peer-reviewed international journals

Longitudinal changes of CSF biomarkers in Alzheimer's disease. Seppälä TT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka SK. J Alzheimers Dis. 2011;25(4):583-94. 

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. Niklas Mattsson, Henrik Zetterberg, Elisabet Londos, Niels Andreasen, Alessia Lanari, Michael Jonsson, Sanna-Kaisa Herukka, Wiesje M van der Flier, Michael Evers, Kenneth Rich, Elmar Kaiser, Erik Rosén, Dag Aarsland, Pieter Jelle-Visser, Johannes Schröder, Jan Marcusson, Mony de Leon, Harald Hampel, Philip Scheltens, Tuula Pirttilä, Anders Wallin, Lucilla Parnetti, Maria Eriksdotter, Jönhagen, Lennart Minthon, Bengt Winblad, Kaj Blennow. JAMA 2009;302(4):385-93. 

CSF beta-amyloid and Tau proteins are markers of Alzheimer-type pathology in the brain. Tero Tapiola, Irina Alafuzoff, Sanna-Kaisa Herukka, Laura Parkkinen, Päivi Hartikainen, Hilkka Soininen, Tuula Pirttilä. Arch Neurol, 2009;66(3):382-9.

PET amyloid ligand [11C]PIB uptake and CSF Abeta in MCI. Jaana Koivunen,  Tuula Pirttilä,  Nina Kemppainen, Sargo Aalto,  Sanna-Kaisa Herukka, Anne Hämäläinen, Tuomo Hänninen, Merja Hallikainen, Kjell Någren, Juha O. Rinne, Hilkka Soininen. Dement Geriatr Cogn Disord 2008;26(4):378-383.

Cerebrospinal fluid Aß42, Tau and phosphorylated Tau correlate with hippocampal atrophy. Sanna-Kaisa Herukka, Corina Pennanen, Hilkka Soininen, Tuula Pirttilä. J Alzheimers Dis 2008;14(1):51-7.

The association study between DHCR24 polymorphisms and Alzheimer's disease. Riikka Lämsä, Seppo Helisalmi, Mikko Hiltunen, Sanna-Kaisa Herukka, Tero Tapiola, Tuula Pirttilä, Saila Vepsäläinen, Hilkka Soininen. Am J Genet B Neuropsychiatr Genet 2007;144B(7):906-10.

Genetic study evaluating LDLR polymorphisms and Alzheimer's disease. Riikka Lämsä, Seppo Helisalmi, Sanna-Kaisa Herukka, Tero Tapiola, Tuula Pirttilä, Saila Vepsäläinen, Mikko Hiltunen, Hilkka Soininen. Neurobiol Aging 2008;29(6):848-55.

CSF Aß42, Tau and phosphorylated Tau, APOE ε4 allele and MCI type in progressive MCI. Sanna-Kaisa Herukka, Seppo Helisalmi, Merja Hallikainen, Susanna Tervo, Hilkka Soininen, Tuula Pirttilä. Neurobiol Aging 2007;28(4):507-14.

CSF Aß42 and Tau or phosphorylated Tau and prediction of progressive mild cognitive impairment. Sanna-Kaisa Herukka, Merja Hallikainen, Hilkka Soininen, Tuula Pirttilä. Neurology 2005;64(7):1294-7.